BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SFARI - ECPv6.6.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SFARI
X-ORIGINAL-URL:https://www.sfari.org
X-WR-CALDESC:Events for SFARI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20140101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20140423T170000
DTEND;TZID=UTC:20140423T181500
DTSTAMP:20260513T181554
CREATED:20140423T080000Z
LAST-MODIFIED:20180216T202659Z
UID:2006-1398272400-1398276900@www.sfari.org
SUMMARY:New approaches to treating Rett syndrome
DESCRIPTION:  \n\n\n\nOn 23 April\, Gail Mandel presented the complex pathology of Rett syndrome and discussed whether this autism-related disorder would be amenable to gene replacement strategies. Her talk was part of the Simons Foundation Autism Research lecture series. You can watch a complete video recording of the event above. \nAbout the Lecture\nA central goal in neuroscience is determining the genetic basis of neurological disorders — from autism to brain tumors. Many of these pathological states result from defects in gene regulatory programs that are fundamental to all cell types but lead to dysfunction specifically within the nervous system. Mandel investigates the basis of this phenomenon and has identified cell-cell interactions between neurons and glia — brain cells that support neurons and help process information — involved in brain development. \nMandel has been able to treat the brain pathology of one autism-related disorder\, Rett syndrome\, by genetically replacing the defective MeCP2 gene with a good copy of the gene in astrocytes — a type of glia. She is exploring the underlying mechanisms crucial for neuronal signaling. \nAbout the speaker:\nGail Mandel holds a Ph.D. in immunology from the University of California\, Los Angeles\, and did postdoctoral work in biochemistry and molecular biology there and at the University of California\, San Diego\, and Harvard Medical School. She began her career at Tufts Medical School\, where she was one of the first investigators to clone and express mammalian voltage-dependent ion channels. In the department of neurobiology and behavior at Stony Brook University\, she identified the protein REST\, which is responsible for regulation of sodium channel expression and the acquisition of cellular excitability. These discoveries have helped unlock the mechanisms through which embryonic cell types differentiate specifically into neurons. Mandel is a senior scientist in the Vollum Institute at Oregon Health & Science University. She is an Investigator of the Howard Hughes Medical Institute and a member of the American Academy of Sciences and the National Academy of Sciences. \n  \n  \n 
URL:https://www.sfari.org/event/new-approaches-to-treating-rett-syndrome/
LOCATION:Gerald D. Fischbach Auditorium\, 160 5th Avenue\, New York\, NY\, 10010\, United States
ATTACH;FMTTYPE=image/jpeg:https://sf-web-assets-prod.s3.amazonaws.com/wp-content/uploads/sites/2/2017/08/04213119/GailMandel250.jpg
END:VEVENT
END:VCALENDAR